Yorke Justin W 4/A
4/A · Processa Pharmaceuticals, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4/AAmended
Yorke Justin W
Director
Transactions
- Exercise/Conversion
Common Stock
2022-08-05+1,169→ 14,885 total
Holdings
- 532,563(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Vesting of time-based restricted shares.
- [F2]Previous filing inadvertently underreported shares beneficially owned by the reporting person.